Multicompartment Models

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
Clinical Pharmacokinetics
PHARMACOKINETIC.
Linear Equations Review. Find the slope and y intercept: y + x = -1.
Extravascular administration: monitoring drug in urine.
Pharmacokinetics of Drug Absorption
Nonlinear pharmacokinetics
Two-compartment model
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
One-compartment open model: Intravenous bolus administration
Week 5- Pharmacokinetics of oral absorption
Pharmacokinetics Calculations
Week 3 - Biopharmaceutics and Pharmacokinetics
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Week 4 - Biopharmaceutics and Pharmacokinetics
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
Body Systems Overview 1.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Karunya Kandimalla, Ph.D. Assistant Professor, Pharmaceutics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics Prepared By, Jahanvi H. Patel Roll No:09MPH103 Dept: Pharmaceutical Technology & Biopharmaceutics Guided By: Dhaivat C. Parikh.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
PHARMACOKINETIC MODELS
Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Bioscience, National University of Sciences and Technology 21 st October, 2013.
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
One Compartment Open Model IV bolus
Drug distribution and protein binding
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
Calculation of Doses Prof. Dr. Henny Lucida, Apt.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
CHAPTER 7 ABSORPTION KINETICS.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Nonlinear Pharmacokinetics
Prof. Dr. Henny Lucida, Apt
Design of Sustained Release Dosage Forms
Clinical Pharmacokinetic Equations and Calculations
ــــــــــــــ February 17 th, PHT - LECTURE Mathematical Fundamental in Pharmacokinetics Dr. Ahmed Alalaiwe.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
415 PHT Plasma Level – Time Curve
Pharmacokinetics 3rd Lecture
MULTIPLE DOSAGE REGIMEN
Drug Response Relationships
Compartmental Models and Volume of Distribution
Physiology for Engineers
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
F-IF.C.7a: Graphing a Line using Slope-Intercept, Part 2
Quantitative Pharmacokinetics
The Changes of Concentration with Time
Therapeutic Drug Monitoring
Hawler Medical University
Clinical Pharmacokinetics
1-C: Renal and Hepatic Elimination
A medical researcher wishes to determine how the dosage (in mg) of a drug affects the heart rate of the patient. Find the correlation coefficient & interpret.
Presentation transcript:

Multicompartment Models Prof. Dr. Henny Lucida, Apt

These models were developed to explain the observation that, after a rapid IV injection, the Cp vs t curve does not decline linearly as a single, first order process. The drug distributes at various rates into different tissue groups. After drug equilibration within the peripheral tissues, the Cp vs t curve reflects first-order elimination of the drug from the body

General Groupin of Tissues according to Blood Supply Tissue Group % BW Highly perfused Heart, brain, hepatic-portal system, kidney and endocrine glands Skin and muscle Adipose (fat) tissue & marrow 9 50 19 Slowly perfused Bone, ligaments, tendons, cartilage, teeth and hair 22

Two-Compartment open model The plasma drug concentration declines biexponentially as the sum of two first-order processes– distribution and elimination. The drug distributes into 2 comp: the central comp and the tissue (peripheral) comps. Drug transfer between the two comps is assumed to take place by first-order process.

Basic Equations

Residual Method Example: 100 mg of a drug was administered by rapid IV injection to a 70-kg, healthy adult male. Blood samples were taken periodically after the administration of drug, and the plasma fraction of each sample was assayed for drug. The following data were obtained:

Time (hr) Cp (mg/mL) 0.25 43.00 4.0 6.50 0.5 32.00 8.0 2.80 1.0 20.00 12.0 1.20 1.5 14.00 16.0 0.52 2.0 11.00

Step1. Transform data to log Cp Time (hr) Log Cp 0.25 1.6335 4.0 0.8129 0.5 1.5051 8.0 0.4472 1.0 1.3010 12.0 0.0792 1.5 1.1461 16.0 -0.2840 2.0 1.0414

Plot log Cp vs time a b

Step 2. Determine the linear regression of line b (after 4 hr), these data represent only the elimination process thus the slopeof line is equal to K The linear regression: Y1=1.1785 – 0.0915 X1 (r=-0.9999) Slope = -0.0915; b = 0.2107/hr B=antilog 1.1785= 15.0834 mg/mL Equation for b : Cp = 15.08 e-0.21t

Then: k, k12 and k21 can be calculated. Step 3. The ka is determined residually by subtracting the data point at < 4 hr with the fitted data using linear regression of b. At these data point, the absorption process is predominant, then the slope would be the ka. This step would be easily solved by using a semi-logarithmic paper. Then the linear regression of the subtracted data is determined: Y2 = 1.6727 – 0.8055 X2 The slope = -0.8055, then a or ka = 1.8551/hr The intercept = 1.6727, then A or the C0 = antilog 1.6727 = 47.0652 mg/mL. Equation for a : Cp = 47.06 e-1.85t Thus the profile of plasma conc based on two compartment model is Cp = 47.06 e-1.85t + 15.08 e-0.21t Then: k, k12 and k21 can be calculated.

Problems A drug was administered by rapid iv injection into a 70-kg adult male. Blood samples were withdrawn over a 7-hour period and assayed for intact drug. The results are tabulated below. Using the method of residuals, calculate the values for intercepts A and B and slopes a, b, k, k12 and k21.

Time (hr) Cp (mg/mL) 0.00 70.0 2.5 14.3 0.25 53.8 3.0 12.6 0.50 43.3 4.0 10.5 0.75 35.0 5.0 9.0 1.00 29.1 6.0 8.0 1.50 21.2 7.0 2.00 17.0